CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
Sven H. Loosen(Düsseldorf University Hospital), Tom Luedde(Heinrich Heine University Düsseldorf), Thomas Longerich(Heidelberg University), Katja L. Kauertz(RWTH Aachen University), Marcel Binnebösel(RWTH Aachen University), Alexander Koch(RWTH Aachen University), Mihael Vucur(Düsseldorf University Hospital), Tom Florian Ulmer(Maastricht University Medical Centre), Frank Tacke(Charité - Universitätsmedizin Berlin), Ulf P. Neumann(RWTH Aachen University), Anne T. Schneider(Düsseldorf University Hospital), Georg Lurje(Charité - Universitätsmedizin Berlin), Christoph Roderburg(Universitätsklinikum Aachen), Cornelis H.C. Dejong(Maastricht University), Wenzel Schoening(RWTH Aachen University), Christian Trautwein(TUM Klinikum)
Cited by 99
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
|Hepatology|2010|786